The level of proof to guidance the use of tramadol and tapentadol in musculoskeletal or cancer-relevant Persistent discomfort is reduced. In scientific trials, the incidence of constipation and the rate of review dropout for constipation had been appreciably lower with tapentadol than with oxycodon